L
ADING

Research & Development

First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients
First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients
Merrimack Pharmaceuticals, Inc. has announced updated clinical data from a multi-arm Phase 1 study of MM-141, a bispecific antibody targeting
Read more.
BCM-95 Curcumin and BosPure Boswellia in Prevention and Treatment of Colorectal Cancer
BCM-95 Curcumin and BosPure Boswellia in Prevention and Treatment of Colorectal Cancer
In the first study of its kind, researchers have demonstrated novel and previously unknown mechanisms of action
Read more.